IMAC Holdings - BACK Business Value to Revenue

Public company logo of imacholdings.comm (BACK)

IMAC Holdings, Inc. (BACK) faces a capital deficit and a reliance on private client payments amid chronic losses. This chart of the EV/Revenue multiple demonstrates volatility, with the metric currently at . The implementation of robotic physical therapy reduces the burden on staff, while the ongoing restructuring of the clinic network is only beginning to yield initial results on the path to profitability.

IMAC Corp (BACK): Enterprise Value-to-Revenue Ratio from 07/04/2022 to 11/20/2026

IMAC Corp - analytical breakdowns and key metrics (BACK)

Initial company analysis:IMAC Holdings, Inc., BACK
Finished products of IMAC Regeneration Centers

Investors are assessing the resilience of IMAC Holdings, Inc. (BACK) via the EV/Sales ratio, which compares the total enterprise value (market capitalization and debt) to sales volume, eliminating the impact of financial leverage. By analyzing the enterprise value-to-revenue trend, one can determine how effectively the digitalization of clinics and the transition away from paper documentation optimize operating expenses, thereby influencing the company's market multiple.

Competitor analysis for IMAC Holdings, Inc.

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Company Value to Revenue|NIVF (NewGenIvf Group Limited) - Enterprise Value-to-Revenue Ratio|ATIP (ATI Physical Therapy Inc.) - EV/Sales Multiple|EV/Sales Multiple CareMax Inc.|Enterprise Value-to-Revenue Ratio Kindly MD Inc (KDLY)|Company Value to Revenue ModivCare Corp MODV|Novo Integrated - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient SSY (SunLink Health Systems)